Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Novel Communications in Diabetes

Age at Menarche and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study Among 27,482 Women

  1. Liwei Chen1⇑,
  2. Shanshan Li2,
  3. Chunyan He3,
  4. Yeyi Zhu2,
  5. Germaine M. Buck Louis2,
  6. Edwina Yeung2,
  7. Frank B. Hu4,5,6 and
  8. Cuilin Zhang2
  1. 1Department of Public Health Sciences, Clemson University, Clemson, SC
  2. 2Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
  3. 3Department of Public Health, and Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN
  4. 4Department of Nutrition, Harvard School of Public Health, Boston, MA
  5. 5Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
  6. 6Department of Epidemiology, Harvard School of Public Health, Boston, MA
  1. Corresponding author: Liwei Chen, liweic{at}clemson.edu.
  1. L.C. and S.L. contributed equally to this study.

Diabetes Care 2016 Mar; 39(3): 469-471. https://doi.org/10.2337/dc15-2011
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE To examine the association between age at menarche and risk of gestational diabetes mellitus (GDM).

RESEARCH DESIGN AND METHODS A prospective cohort study of 42,109 eligible pregnancies from 27,482 women in the Nurses’ Health Study II.

RESULTS The adjusted risk ratios for GDM across the age at menarche categories (≤11, 12, 13, and ≥14 years) were 1.34 (95% CI 1.14–1.58), 1.13 (0.97–1.31), 1.11 (0.95–1.29), and 1.00 (referent; P for trend = 0.0005), respectively. Analysis of the mediating effect indicated that 42.1% (P = 0.0007) of the association was mediated through prepregnancy BMI.

CONCLUSIONS These findings suggested that earlier menarche was significantly associated with an increased risk of GDM. This association was largely mediated through prepregnancy excessive body adiposity.

Introduction

Gestational diabetes mellitus (GDM) is one of the most common pregnancy complications, affecting ∼2–7% of all pregnancies in the U.S. (1). Identifying women who are at high risk of GDM has important public health and clinical significances. Menarche is an indicator of pubertal onset and the beginning of reproductive life in women. Although early menarche has been associated with risk factors for GDM, such as insulin resistance (2,3) and obesity (4–6), the association between age at menarche and risk of GDM has yet to be investigated. The objective of this study was to examine the association between menarche timing and GDM risk, and the extent to which the association is mediated through prepregnancy obesity.

Research Design and Methods

The Nurses’ Health Study II, initiated in 1989, is an ongoing prospective cohort of U.S. female nurses. For the current study, the final sample included 27,482 women (42,109 eligible pregnancies) who did not have diabetes and other major chronic diseases at baseline or prior to GDM, and were observed until 2001 (after which most women had passed the reproductive age).

GDM events were identified based on self-reported information and updated every 2 years. A previous validation study (7) demonstrated a high validity of self-reported diagnosis of GDM in this cohort (94% of women who reported to have GDM were confirmed by a physician review based on medical record review). Age at menarche was defined as the age of the first menstruation and was collected in 1989 (baseline questionnaire).

Age at menarche was grouped into a categorical variable (≤11, 12, 13, and ≥14 years of age) to ensure adequate sample size in each age category. Log-binomial models were performed to estimate the risk ratio (RR) and 95% CI of GDM associated with age at menarche, with generalized estimating equations assuming a similar within-person correlation across two or more pregnancies for a single woman. Multivariate regression models were applied to control for potential confounding factors. The mediating effect was evaluated by calculating the mediation proportion that represents the proportion for excess risk of GDM that can be attributed to a mediator.

Results

We documented 1,404 pregnancies complicated by GDM (346 were recurrent GDM) among 27,482 women (92% were Caucasian). The mean age at menarche was 12.6 ± 1.5 years, and the median was 12.0 years. In general, women with an earlier age at menarche had a lower birth weight, a larger body size at age 5 and 10 years, a greater BMI at age 18 years, and a greater weight gain since age 18 years (Supplementary Table 1). Moreover, they were more likely to be overweight or obese before pregnancy, to have a higher BMI at 18 years of age and before the index pregnancy, and to gain more weight since 18 years of age than women with older ages at menarche. Early menarche was significantly associated with an increased risk of GDM (Table 1). After adjusting for age, race/ethnicity, and family history of diabetes, pregnancies among women with menarche at ≤11 years of age had a 39% increased risk of GDM (RR 1.39, 95% CI 1.19–1.63) compared with pregnancies among women with menarche at 14 years of age (referent) (multivariate model 1). The association did not change, and the trend remained significant with additional adjustment for women’s birth weight, and somatotype at ages 5 and 10 years (P for trend = 0.0003; multivariate model 2), suggesting that the association between age at menarche and GDM is not confounded by intrauterine and childhood adiposity before the onset of menarche. After further adjustment for adulthood lifestyle factors (i.e., alcohol consumption, smoking status, Alternate Healthy Eating Index 2010, total physical activity, marital status, and oral contraceptive use in model 3), the RRs across the menarche categories (≤11, 12, 13, and ≥14 years of age) were 1.34 (95% CI 1.14–1.58), 1.13 (0.97–1.31), 1.11 (0.95–1.29), and 1.00 (referent; P for trend = 0.0005; multivariate model 3), respectively, indicating that the association is independent of adulthood lifestyle factors.

View this table:
  • View inline
  • View popup
Table 1

Relative risk (95% CI) of GDM according to age at menarche among 42,109 pregnancies in the Nurses’ Health Study II (1,404 GDM events)

To further understand how body weight/adiposity after the onset of menarche impacts the menarche-GDM association, we tested the results by adding adolescent and adulthood BMI in the multivariate models. Additional adjustment for BMI at 18 years of age did not materially change the results. The association, however, was substantially attenuated and became statistically insignificant after further adjustment of prepregnancy BMI (data not shown). We further calculated the proportions of effects mediated through prepregnancy BMI. The estimated proportion for excess risk of GDM was 42.1% (95% CI 17.9–66.3, P = 0.0007) for prepregnancy BMI, indicating that prepregnancy BMI was a mediator for the associations between age at menarche and GDM risk.

Conclusions

Two major findings were observed from this prospective study of 42,109 pregnancies among 27,482 women. First, earlier menarche was significantly associated with an increased risk of GDM, independent of established risk factors, such as age, parity, family history of diabetes, smoking, oral contraceptive use, physical activity, birth weight, and childhood adiposity. Second, the association between age at menarche and GDM risk might be partly mediated through prepregnancy obesity.

We were aware of one previous study that examined the relationship between age at menarche and GDM among 3,419 women (185 GDM events), and reported no association. Our findings provide new evidence that earlier menarche is associated with GDM and are generally in agreement with several recent large cohort studies (8–13) in which earlier menarche was significantly associated with an increased risk of type 2 diabetes in middle- to old-aged adults. The precise mechanism by which early age at menarche may increase the risk of GDM is not clear. Early menarche has been associated with risk factors for GDM such as excessive prepregnancy obesity (4–6) and insulin resistance (2,3). In the current study, the observed association was substantially attenuated after adjusting for prepregnancy BMI. The estimated proportion of risk of GDM that was mediated by prepregnancy BMI was 42.1%, suggesting that prepregnancy adiposity may play an important role in mediating this association. Other pathways might also be implicated in the association between age at menarche and GDM. Earlier age at menarche was associated with adulthood higher estrogen levels and lower serum sex hormone–binding globulin levels among women (14). High plasma estradiol and testosterone and/or low sex hormone–binding globulin levels were also associated with a higher risk of GDM (15), independent of adiposity. Therefore, it is plausible that age at menarche may be related to GDM risk through its association with hormonal changes. Future studies to investigate the underlying mechanisms are warranted.

In summary, earlier age at menarche was associated with an elevated risk of GDM. A large proportion, but not all, of this association was mediated through excessive adiposity before pregnancy. Early age at menarche might represent another risk factor for the early identification of girls who are at increased risk of the development of GDM in adulthood.

Article Information

Funding. The Nurses’ Health Study II was funded by research grants CA-50385 and DK-58845 from the National Institutes of Health. When this study was conducted, L.C., S.L., Y.Z., G.M.B.L., E.Y., and C.Z. were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. L.C. conceived and designed the study, conducted statistical analyses, and wrote the first draft of the manuscript. S.L. conceived and designed the study and conducted statistical analyses. C.H. conceived and designed the study. Y.Z. interpreted results and revised the manuscript. G.M.B.L. and E.Y. contributed to discussions. F.B.H. acquired data. C.Z. conceived and designed the study, and acquired data. All authors interpreted results and revised the manuscript. L.C. and C.Z. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Footnotes

  • This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc15-2011/-/DC1.

  • Received September 13, 2015.
  • Accepted November 23, 2015.
  • © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

References

  1. ↵
    1. American Diabetes Association
    . Gestational diabetes mellitus. Diabetes Care 2004;27(Suppl. 1):S88–S90pmid:14693936
    OpenUrlCrossRefPubMed
  2. ↵
    1. Feng Y,
    2. Hong X,
    3. Wilker E, et al
    . Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008;196:590–597pmid:17675039
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Kivimäki M,
    2. Lawlor DA,
    3. Smith GD, et al
    . Association of age at menarche with cardiovascular risk factors, vascular structure, and function in adulthood: the Cardiovascular Risk in Young Finns study. Am J Clin Nutr 2008;87:1876–1882pmid:18541580
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Laitinen J,
    2. Power C,
    3. Järvelin MR
    . Family social class, maternal body mass index, childhood body mass index, and age at menarche as predictors of adult obesity. Am J Clin Nutr 2001;74:287–294pmid:11522550
    OpenUrlAbstract/FREE Full Text
    1. Freedman DS,
    2. Khan LK,
    3. Serdula MK,
    4. Dietz WH,
    5. Srinivasan SR,
    6. Berenson GS; Bogalusa Heart Study
    . The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa Heart Study. BMC Pediatr 2003;3:3pmid:12723990
    OpenUrlCrossRefPubMed
  5. ↵
    1. Pierce MB,
    2. Leon DA
    . Age at menarche and adult BMI in the Aberdeen children of the 1950s cohort study. Am J Clin Nutr 2005;82:733–739pmid:16210700
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Solomon CG,
    2. Willett WC,
    3. Carey VJ, et al
    . A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078–1083pmid:9315766
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Saquib N,
    2. Kritz-Silverstein D,
    3. Barrett-Connor E
    . Age at menarche, abnormal glucose tolerance and type 2 diabetes mellitus: the Rancho Bernardo Study. Climacteric 2005;8:76–82pmid:15804735
    OpenUrlCrossRefPubMedWeb of Science
    1. Lakshman R,
    2. Forouhi N,
    3. Luben R, et al
    . Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia 2008;51:781–786pmid:18320165
    OpenUrlCrossRefPubMedWeb of Science
    1. He C,
    2. Zhang C,
    3. Hunter DJ, et al
    . Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010;171:334–344pmid:20026580
    OpenUrlAbstract/FREE Full Text
    1. Stöckl D,
    2. Döring A,
    3. Peters A, et al
    . Age at menarche is associated with prediabetes and diabetes in women (aged 32-81 years) from the general population: the KORA F4 Study. Diabetologia 2012;55:681–688pmid:22170465
    OpenUrlCrossRefPubMed
    1. Elks CE,
    2. Ong KK,
    3. Scott RA, et al.; InterAct Consortium
    . Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care 2013;36:3526–3534pmid:24159179
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Mueller NT,
    2. Duncan BB,
    3. Barreto SM, et al
    . Earlier age at menarche is associated with higher diabetes risk and cardiometabolic disease risk factors in Brazilian adults: Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Cardiovasc Diabetol 2014;13:22pmid:24438044
    OpenUrlCrossRefPubMed
  9. ↵
    1. Apter D,
    2. Reinilä M,
    3. Vihko R
    . Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989;44:783–787pmid:2511157
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Bartha JL,
    2. Comino-Delgado R,
    3. Romero-Carmona R,
    4. Gomez-Jaen MC
    . Sex hormone-binding globulin in gestational diabetes. Acta Obstet Gynecol Scand 2000;79:839–845pmid:11304966
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 39 (3)

In this Issue

March 2016, 39(3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Age at Menarche and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study Among 27,482 Women
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Age at Menarche and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study Among 27,482 Women
Liwei Chen, Shanshan Li, Chunyan He, Yeyi Zhu, Germaine M. Buck Louis, Edwina Yeung, Frank B. Hu, Cuilin Zhang
Diabetes Care Mar 2016, 39 (3) 469-471; DOI: 10.2337/dc15-2011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Age at Menarche and Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study Among 27,482 Women
Liwei Chen, Shanshan Li, Chunyan He, Yeyi Zhu, Germaine M. Buck Louis, Edwina Yeung, Frank B. Hu, Cuilin Zhang
Diabetes Care Mar 2016, 39 (3) 469-471; DOI: 10.2337/dc15-2011
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Conclusions
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes
  • Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial
  • Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up
Show more Novel Communications in Diabetes

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.